TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
COAG

Hemab Therapeutics Holdings, Inc.

Healthcare · Biotechnology

33.10$ -4.7% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

Hemab Therapeutics Holdings, Inc. (COAG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 195 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet COAG
Line item 2024 2025
96 195
93 193
74 88
– 185
– 2.6
212 371
6.7 11
– 0.6
3.2 5.7
-115 -177
-118 -182
44 27

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?